Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Biogen Inc | 10% Owner | 2022-08-30 | 100,000 | $5.27 | $526.50kSell |
Biogen Inc | 10% Owner | 2022-08-29 | 400,000 | $5.33 | $2.13MSell |
Scott B. Willoughby | SVP Gen. Counsel & Secretary | 2022-08-13 | 864 | $6.33 | $5.47kSell |
David Mark McClung | EVP Chief Operating Officer | 2022-06-25 | 11,525 | $4.31 | $49.67kSell |
Prathyusha Duraibabu | Vice President Finance | 2022-06-11 | 842 | $3.76 | $3.17kSell |
Prathyusha Duraibabu | SVP Chief Financial Officer | 2022-06-11 | 864 | $3.76 | $3.25kSell |
John Markels | Director | 2022-06-03 | 6,784 | $3.69 | $25.03kBuy |
H. Stewart Parker | Director | 2022-06-01 | 5,000 | $3.60 | $18.00kBuy |
Scott B. Willoughby | SVP Gen. Counsel & Secretary | 2022-04-29 | 140 | $4.15 | $581.00Sell |
Jason D. Fontenot | SVP Chief Scientific Officer | 2022-04-25 | 826 | $4.83 | $3.99kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Biogen Inc | 14.43% | 23,652,466 | $83.02M | Insider |
Blackrock Inc | 8.70% | 14,264,458 | $50.07M | Institution |
Wasatch Advisors Inc | 8.01% | 13,122,116 | $46.06M | Institution |
Vanguard Group Inc | 7.77% | 12,731,109 | $44.69M | Institution |
State Street Corp | 4.25% | 6,968,276 | $24.46M | Institution |
Credit Suisse Ag 1 | 2.32% | 3,803,127 | $13.35M | Institution |
Ra Capital Management LP | 2.25% | 3,683,002 | $12.93M | Insider |
Nuveen Asset Management LLC | 2.05% | 3,355,829 | $11.78M | Institution |
Dimensional Fund Advisors LP | 1.87% | 3,070,841 | $10.78M | Institution |
Rokos Capital Management LLP | 1.85% | 3,026,210 | $10.62M | Institution |